MD446G2 - Method for mamma cancer treatment - Google Patents

Method for mamma cancer treatment

Info

Publication number
MD446G2
MD446G2 MD95-0287A MD950287A MD446G2 MD 446 G2 MD446 G2 MD 446G2 MD 950287 A MD950287 A MD 950287A MD 446 G2 MD446 G2 MD 446G2
Authority
MD
Moldova
Prior art keywords
local
hypermetry
shf
cancer
cancer treatment
Prior art date
Application number
MD95-0287A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD446F1 (en
Inventor
Василе ЖОВМИР
Ion Seremet
Tudor Monul
Виталие МАКИДОН
Original Assignee
Онкологический Институт Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Онкологический Институт Республики Молдова filed Critical Онкологический Институт Республики Молдова
Priority to MD95-0287A priority Critical patent/MD446G2/en
Publication of MD446F1 publication Critical patent/MD446F1/en
Publication of MD446G2 publication Critical patent/MD446G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the medicine, namely, to the oncology and may be used for preoperation mamma cancer treatment.The summary of the invention consists in the fact that additionally before the local SHF-hypermetry during the first and third treatment days here is administrated a local chemotherapy with remedies of the alkylic agents and autimetabolites group.The technical result consists in the administration of local chemotherapy in combination with the local SHF-hypermetry in the preparation periode that conducts to the tumor and plural invasive cancer seats destruction increasing, that enables to reduce the cancer cells diffusion during the operation, reducing the local and distant metastasizing recidivation progress.
MD95-0287A 1995-07-07 1995-07-07 Method for mamma cancer treatment MD446G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD95-0287A MD446G2 (en) 1995-07-07 1995-07-07 Method for mamma cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD95-0287A MD446G2 (en) 1995-07-07 1995-07-07 Method for mamma cancer treatment

Publications (2)

Publication Number Publication Date
MD446F1 MD446F1 (en) 1996-03-29
MD446G2 true MD446G2 (en) 1996-11-30

Family

ID=19738701

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0287A MD446G2 (en) 1995-07-07 1995-07-07 Method for mamma cancer treatment

Country Status (1)

Country Link
MD (1) MD446G2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3229G2 (en) * 2006-06-30 2007-07-31 Василе ЖОВМИР Method of mammary cancer preoperative treatment
MD3248G2 (en) * 2006-06-30 2007-09-30 Василе ЖОВМИР Method of mammary cancer treatment
MD3772G2 (en) * 2008-05-12 2009-07-31 Общественное Медико-Санитарное Учреждение Онкологический Институт Method for treating mammary cancer with metastases
MD23Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method of differential treatment of noninvasive lobular mammary carcinoma in situ
MD35Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland
MD36Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method for differential treatment of noninvasive ductal carcinoma in situ of mammary gland
MD24Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method of differential treatment of noninvasive mammary carcinoma

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2849G2 (en) * 2005-05-16 2006-04-30 Василе ЖОВМИР Method of mammary cancer treatment to patients of old age

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
I.Bârzu, C.Drăgănescu. Tratamentul locoregional cu citostatice al mastitei carcinomatoase. "Cancerul sânului". Experienţa românească. Cluj-Napoca. vol. 7, 1981, p. 535. *
Z.Dreznic, L.Falk, U.Ambus et.al. Tratament of malignant neoplasms with radiofrequency hipertermia - clinical experience. Recent adv.med.thermol - New-York, London, 1984, p. 679-688. *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3229G2 (en) * 2006-06-30 2007-07-31 Василе ЖОВМИР Method of mammary cancer preoperative treatment
MD3248G2 (en) * 2006-06-30 2007-09-30 Василе ЖОВМИР Method of mammary cancer treatment
MD3772G2 (en) * 2008-05-12 2009-07-31 Общественное Медико-Санитарное Учреждение Онкологический Институт Method for treating mammary cancer with metastases
MD23Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method of differential treatment of noninvasive lobular mammary carcinoma in situ
MD35Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method for appreciating the risk of development of the noninvasive carcinoma in situ of the mammary gland
MD36Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method for differential treatment of noninvasive ductal carcinoma in situ of mammary gland
MD24Z (en) * 2008-12-02 2010-01-31 Василе ЖОВМИР Method of differential treatment of noninvasive mammary carcinoma

Also Published As

Publication number Publication date
MD446F1 (en) 1996-03-29

Similar Documents

Publication Publication Date Title
Kozlowski et al. Advanced prostatic carcinoma: early versus late endocrine therapy
HK1043313A1 (en) Docetaxel in combination with rhumab her2 for the treatment of cancers
MXPA03010121A (en) Combination therapy using anti-egfr antibodies and anti-hormonal agents.
UA42806C2 (en) System for the simultaneous trans-dermal introduction of several active agents
MD446G2 (en) Method for mamma cancer treatment
MY116474A (en) Potentiation of temozolomide in human tumour cells
MX2024012131A (en) Pharmaceutical composition, use thereof, and method for treating cancer
Klocker et al. Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck
Bonneterre et al. Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
AU4338501A (en) Combination chemotherapy
DK0980205T3 (en) Use of a combination of TALL-104 cells with adriamycin or cisplatin in the treatment of malignancies
MD798G2 (en) Method of the mamma cancer treatment
MD1569G2 (en) Method of treatment of breast canceeeer in the preoperation period
Edelman et al. Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy
WO2003075832A3 (en) Methods and composition based on discovery of metabolism of nitroclycerin
Senn et al. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
CA2368676A1 (en) Sphingomyelin containing preparation
NZ501641A (en) Ganglioside immunostimulating complexes and their use in treating cancer
Park et al. Analysis of the treatment results of localized conventional radiotherapy for early-and advanced-stage cutaneous T-cell lymphoma refractory to other skin-directed therapies
Dobrowsky et al. 7 Continuous hyperfractionated accelerated radiotherapy and mitomycin C in head and neck cancer
Nitsche et al. Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-α in pancreatic and periampullary cancer: Results of a feasibility study
Weiss et al. A randomized trial of postoperative five-versus three-drug chemotherapy after mastectomy: a Cancer and Leukemia Group B (CALGB) study
DE59712247D1 (en) MAMMA CARCINOMA ASSOCIATED GEN
Atzpodien et al. Treatment of Metastatic Colorectal Cancer Patients with 5-Fluorouracil in Combination with Recombinant Subcutaneous Human lnterleukin-2 and Alpha-lnterferon

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20150707